ORGO

Handel nachbörslich: 2.50 -0.010 -0.40%

Organogenesis Holdings Inc (ORGO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Organogenesis Holdings Inc

Healthcare (1110)

781-575-0775

85 DAN ROAD, CANTON, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ORGO's Discussions on Twitter

Compare ORGO vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ORGO Organogenesis Holdings Inc	2.51	306.16M	564.17M	37.03M	-24.46M	0.1095
TAK Takeda Pharmaceutical Co Adr	17.85	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	121.11	49.56B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	43.86B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.77	35.89B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	578.54	25.06B	3.18B	1.33B	1.04B	27.90

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-28	Eingeleitet	Lake Street	Buy
2024-02-07	Eingeleitet	Cantor Fitzgerald	Overweight
2023-06-15	Eingeleitet	Morgan Stanley	Equal-Weight
2023-05-24	Hochstufung	BTIG Research	Neutral → Buy
2022-11-10	Herabstufung	BTIG Research	Buy → Neutral
2022-08-10	Herabstufung	Oppenheimer	Outperform → Perform
2020-01-10	Eingeleitet	SVB Leerink	Outperform
2019-08-26	Fortgesetzt	Credit Suisse	Outperform
2019-05-02	Eingeleitet	Credit Suisse	Outperform
2019-04-17	Eingeleitet	Oppenheimer	Outperform
2019-04-11	Eingeleitet	SunTrust	Buy

Alle ansehen

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Compare ORGO vs TAK, ZTS, HLN, TEVA, UTHR

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

Organogenesis rises as PuraPlyAM succeeds in diabetic foot ulcers - MSN

3 Penny Stocks With Market Caps Under $400M To Consider - simplywall.st

Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens - FinancialContent

Organogenesis shares jump 20% following positive clinical trial results - MSN

What's going on with Organogenesis stock on Wednesday? - MSN

Options Flow: Will Organogenesis Holdings Inc benefit from rate cuts2026 EndofMonth & Stepwise Trade Execution Plans - baoquankhu1.vn

720p-h264Dailyhunt - Dailyhunt

What's Going On With Organogenesis Stock On Wednesday? - Sahm

Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight (NASDAQ:ORGO) - Seeking Alpha

Organogenesis stock rockets after diabetic foot ulcer trial posts statistically significant win - MSN

PuraPly AM Triumphs in Wound Healing Trial, Paves Way for New Successes - StocksToTrade

Organogenesis’ Clinical Trials Propel Stock Amid FDA Progress - timothysykes.com

Organogenesis stock surges 20% on trial results By Investing.com - Investing.com Australia

Organogenesis Stock Rockets After Diabetic Foot Ulcer Trial Posts Statistically Significant Win - Benzinga

Organogenesis stock surges 20% on trial results - Investing.com

Organogenesis stock up as PuraPlyAM succeeds (ORGO:NASDAQ) - Seeking Alpha

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026 - Bitget

Organogenesis plans rolling BLA submission for ReNu by year-end - Investing.com Canada

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPlyAM - Bitget

ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment - Stocktwits

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM - The Manila Times

In 170-patient diabetic foot ulcer study, Organogenesis clears key goal - Stock Titan

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu for Knee Osteoarthritis Pain - Bitget

Organogenesis Cleared to Begin Rolling BLA for ReNu Knee Osteoarthritis Therapy - marketscreener.com

Regenerative medicine giant Organogenesis Holdings Inc (ORGO) recently announced the successful completion of a key meeting with the U.S. Food and Drug Administration (FDA). - Bitget

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times

Knee pain treatment for 31 million Americans moves toward FDA filing - stocktitan.net

New York real estate firm acquires Organogenesis property for $68M - Providence Business News

ORGO SEC FilingsOrganogenesis Hldgs Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Movement Recap: Whats the fair value of Organogenesis Holdings Inc stockQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn

Published on: 2026-03-31 10:52:09 - baoquankhu1.vn

IPO Launch: Is Organogenesis Holdings Inc impacted by rising rates2026 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn

Dividend Watch: Whats the fair value of Organogenesis Holdings Inc stock2026 Technicals & Weekly High Conviction Ideas - baoquankhu1.vn

Organogenesis Facing Hard Times As It Adjusts To CMS Rule Changes (NASDAQ:ORGO) - Seeking Alpha

Asia Pacific Wound Care Biologics Market Projected to Witness - openPR.com

Organogenesis (NASDAQ:ORGO) Receives “Buy” Rating from BTIG Research - Defense World

BTIG Reiterates Buy Rating and $8 Price Target for ORGO | ORGO S - GuruFocus

Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO - MarketBeat

Income Plays: Is Organogenesis Holdings Inc benefiting from innovation trendsDividend Hike & Target Return Focused Picks - baoquankhu1.vn

Aug Summary: Is Organogenesis Holdings Inc impacted by rising ratesWatch List & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Trading Recap: How does Organogenesis Holdings Inc correlate with Nasdaq2026 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ORGO